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Abstract 
Using microarray data, a genome wide analysis of hepatic gene-silencing in four hepatoma variant cell 
lines was carried out. The purpose of this analysis was to identify candidate genes that may be able to 
restore liver function in non-functional cell variants, ultimately giving insight into the mechanisms 
behind global hepatic gene expression. Based on a selection scheme allowing only for genes activated or 
repressed at least 5 fold in 2 out of the 4 variant cell lines, 225 genes were found to be repressed while a 
total of 76 genes were found to be activated. Of the repressed genes identified, fourteen candidate 
genes were chosen based on known function as transcription factors or involvement in signal 
transduction pathways. One gene of particular interest, ONECUTl (or HNF6), was analyzed for the 
capability to restore liver function in one of the cell variant lines. This was done by stable transfection of 
ONECUTl into the H11-variant cell line, followed by qPCR to monitor liver gene reactivation. 
Measurement for liver reactivation was assessed by comparing gene expression values of known liver­
specific genes (such as albumin) of parental hepatoma cells to those of variant cell lines. Data indicates 
that ONECUTl is not able to directly restore liver function in the variant cell lines. However, the 
thorough analysis of hepatic gene silencing paves the way for genetic rescue experiments designed to 
identify genes involved with hepatic function and the genetic programs responsible for establishing and 
maintaining liver specific gene expression. 
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Introduction 
The liver is responsible for a variety of functions essential to sustaining life amongst 
vertebrates.1-8 The breadth of hepatic functions and their importance to maintaining homeostasis within 
the body is highlighted by the devastating effects that arise from liver failure. The liver plays a role in the 
digestive system by synthesizing and secreting bile salts (in bile) that solubilize dietary fat.2 Along with its 
digestive functions, it also has excretory, degradative, endocrine, and clotting functions within the 
body.1'3 Among these endocrine factors are secretion of IGF-1,which promotes growth in several tissues, 
and angiotensinogen (to form renin-angiotensinogen complex), which helps regulate blood pressure 
throughout the body.4 It is involved with the excretory system by both excreting and biotransforming 
endogenous and foreign organic molecules, as well as destroying erythrocytes.1 Production of clotting 
factors such as fibrinogen and prothrombin in the liver is essential to coagulation and hemostatic 
processes. 5'6 
Apart from these functions, the liver also plays an important role in several metabolic processes 
occurring throughout the body. Organic metabolic processes in the liver are highlighted by its 
involvement with maintaining blood glucose levels, a major energy source for many cells. The liver plays 
a central role in maintaining blood glucose levels by glycogenesis (uptake/storage), as well as 
glycogenolysis and gluconeogenesis, both of which are involved with the release of glucose.7 
Cholesterol, an important structural component of animal cell membranes responsible for providing fast 
alterations to permeability and fluidity, is also synthesized in the liver. 1 
Given the breadth of hepatic functions, it is understood why liver disease produces devastating 
and typically lethal effects. Com batting liver disease, however, poses significant obstacles. Hepatic 
fibrosis, or accumulation of extracellular matrix leading to scar in the liver, is developed from a wound 
healing in response to an injury.8 This hepatic injury may be caused by a variety of effects, including 
viral, autoimmune, drug induced, or cholestatic and metabolic diseases. Regardless of cause, damage 
3 
and scarring to the liver resulting in hepatic fibrosis ultimately leads to cirrhosis. Cirrhosis, the end-stage 
consequence of fibrosis of the hepatic parenchyma, is characterized by nodule formation that can alter 
liver function, causing problems with one or several of the associated hepatic functions listed above.8 
Currently, there is no way to treat late stage fibrosis or cirrhosis without a transplant. For this reason, it 
is important to understand the basic underlying mechanisms by which genetic programs in the liver are 
established and maintained. In this approach, a tumor cell line model is used to provide insight into 
these questions. 
The genetic programs responsible for establishing and maintaining liver specific gene expression 
have previously been identified; however, the mechanism by which these genes lead to the 
differentiated state remains unclear.9•10 Regulatory circuitry within mammalian hepatocytes has been 
mapped and includes several master regulatory genes that encode proteins which bind to and activate 
liver-specific genes. These proteins include HNFla, FOXA2, HNF4a, and ONECUTl, all of which seem to 
work together to activate hundreds of hepatic genes and also interact amongst each other in 
auto regulatory loops to activate expression of one another.11• 12• 13 Other genetic programs involved with 
maintaining differentiated hepatocytes, however, have not been well established. The purpose of this 
study was to give insight into other genetic programs that may be responsible for leading to this 
differentiated state. 
Identification of genes involved in hepatic phenotype was achieved by conducting a genome­
wide analysis of several rat hepatoma cell lines. These included both a parental cell line (Fg14 - which 
was used as an indicator of functional liver) and four independent variant cell lines (M29, Hll, M38, and 
HS2) that had been stringently selected against (<1 in 100,000 cells) to not possess liver function. 
Although these four variant cell lines are similar in that none of them possess liver function, no 
inference can be made about the mechanism by which each cell line has lost hepatic function. For this 
reason, it cannot be assumed that each cell line lost hepatic liver function via the same pathway. This is 
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further illustrated by previous experiments where stable transfection of certain genes (HNF4 or 
HNFla) into variant cell lines resulted in a recovery of liver specific genes (e.g. al AT) in certain variant 
cell lines (M38, Hll), but not others (HS2, M29).14•15•16 
From this genome wide analysis of parental and variant cell lines, 'candidate' genes that may 
ultimately be capable of restoring liver function in variant cell lines upon stable transfection were 
selected via a stringent selection protocol. This protocol for identification of candidate genes was based 
on two main criteria: First, the genes had to be activated or repressed at least 5 fold in 3/4 or 4/4 variant 
cell lines, and second, they must act as transcription factors or signal transduction factors within the cell. 
These can be labeled as candidate genes because given these two criteria, they have the greatest 
potential to restore liver function in variant cell lines upon transfection, thus giving insight into other 
genetic programs that may be involved with driving liver function. From here, a candidate gene of 
specific interest (ONECUT1/HNF6) was stably transfected back into a variant cell line (Hll) and then 
analyzed for its capability to recover expression of liver specific genes in the variant cell line. 
Methods and Materials 
The cell lines were derived from a rat hepatoma tumor cell line H411EC3 from Mary Weiss's 
laboratory in the 1970's. The parental Fg14 cells are both an adenine phosphoribosyltransferase positive 
(ARPT+) and xanthine-guanine phosphoribosyltransferase positive (GPT+) cell line. This cell line was 
derived by stable transfection of gpt and arpt transgenes which are driven by human al-antitrypsin 
(SERPINAl) gene promoter. The variant cell lines (M29, Hll, M38, and HS2) had been derived from 
Fg14 cell lines by negative selection against ARPT and GPT transgene expression using 20 µg/ml 2,6-
diaminopurine (DAP) and 30 µg/ml 6-thioxanthine, respectively. All cells were grown, expanded, and 
maintained in 1:1 Ham's F-12-Dulbecco's modified Eagles medium containing 5% fetal bovine serum 
and 5 µg/100 ml penicillin-streptomycin. 
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RNA was extracted using a Qiagen RNeasy Mini Kit with DNAsel as according to kit protocols. 
The cells were lysed with RLT buffer and spun through a Qiagen column shredder to homogenize, then 
collected with an RNEasy column. Samples were washed and digested with DNase I for 15 minutes at 
room temperature. RNA integrity was then measured by 285 and 185 rRNA after gel electrophoresis in 
3-(N-morpholino)propanesulfonic acid (MOPS)with 1% agarose - 2.2 M formaldehyde gels. RNA purity 
was then determined by nano-drop spectrophotometry at 260 and 280 nm. Triplicate samples of RNA 
extracted from cultures of each cell line were then used to obtain microarray data. 
Before gene expression levels could be analyzed by the lllumina microarray, the extracted RNA 
had to be converted to usable products for the bead assay. The quality of the RNA was tested using the 
Agilent 2100 Bioanalyzer, which was followed by the conversion of high quality RNA to single stranded 
cDNA using the lllumina Total Prep RNA Amplification Kit. This single stranded cDNA was then converted 
to double stranded cDNA via manufacturer protocol. The double stranded cDNA was used as a template 
for a 14 hour in vitro transcription reaction to produce cRNA. Quality of this cRNA was checked and 
followed by hybridization (16 hours) of 750 ng of each sample to RatRef-12 vl Expression BeadChips. 
Following washing, staining, and scanning via manufacturer protocol, the BeadChips were analyzed 
using the GeneExpression Module (version 1.8.0) of the lllumina GenomeStudio software. 
The lllumina microarray data was obtained from the W.M. Keck Center for Comparative and 
Functional Genomics in the Roy J. Carver Biotechnology Center at the University of Illinois at Urbana­
Champaign. The initial process began by obtaining an average microarray reading for each gene in the 
parental cell line and the four variant cell lines. Fg14, Hll, HS2, and M38 cell lines were run as triplicates 
to minimize false positives, while the M29 cell line only had one data point for each gene. Based on 
average data points, genes that were activated or repressed equal to or greater than fivefold (�5 fold) in 
each variant cell line were extrapolated from the data set. Analyses of shared and unique genes 
(activated and repressed) to each variant cell line was then carried out. 
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Once this data was obtained, the genes that were repressed or activated 5 fold or more in 2 out 
of the 4 cell lines were screened for function using various literature and trusted internet sources. 
Coupled with this 2/4 criterion, candidate genes were then selected based on their involvement with 
signal transduction pathways or their ability to act as transcription factors in the body. After candidate 
genes had been selected, one of specific interest, ONECUTl (HNF6) was reintroduced into one of the 
triplicates of the Hll cell line by stable transfection. After transfection, difference in ONECUTl 
expression levels between the variant cell line (denoted Hll) and the recently transfected cell line (H11-
0NECUT1) was determined by using L'iL'iCT values from a quantitative polymerase chain reaction (qPCR) 
with an Applied Biosystems StepOne Thermocycler using primer sets specific for ONECUTl. The same 
qPCR procedure was then used to determine if any global recovery of hepatic function had been 
achieved by priming for known genes that are established indicators of liver function. These included 
Alb, alat, and Pepck. 
Results 
A genome wide analysis of parental (Fg14) and variant (Hll, M29, HS2, and M38) hepatoma cell 
lines was carried out to provide insight into the genetic pathways responsible for driving mammalian 
liver function. To determine this, triplicate whole-genome experiments were ran using isolated RNA 
from parental and variant cell lines that had been reverse transcribed into single stranded cDNA, which 
was then used to produce double stranded cDNA and transcribed into cRNA, which could then labeled 
with biotin and hybridized to lllumina Beadchip Microarrays (see Materials and Methods). 
To check variability between microarray triplicates of each cell line, analysis of �5 fold 
differences within the parental and variant cell line triplicates was carried out. My results showed very 
modest differences between the approximately 22,500 genes in each of the cell lines. The parental Fg14 
cell line only showed 2 genes varying �5 fold, while two of the variant cell lines (M38 and Hll) only 
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showed 5 genes and 0 genes (respectively) varying �5 fold amongst them. The HS2 cell line showed a 
total of 22 genes that varied �5 fold amongst the triplicates. The M29 cell line is not included because it 
did not include any replicates. (Figure l).To minimize the possibility of false positives showing up in my 
results, two criteria were applied: 1) that genes must show a �5 fold difference between cell lines and 2) 
this difference must be shared in at least 2/4 variant cell lines. 
Analysis of gene repression in cell variants 
To analyze repression in cell variants, genes that were repressed at least 5 fold in cell variants 
were assessed. The number of genes repressed in each cell line ranged from 230-284, with M38, HS2, 
M29, and Hll having 232, 253, 284, and 230 genes repressed respectively (Figure 2A).Following 
identification of repressed genes in individual cell lines, comparisons of shared genes between variant 
cell lines was carried out (criteria #2). From this analysis, 268 genes were found to be shared between at 
least 2/4 cell lines, while 132 (49%) of these genes were shared between 4/4 cell lines (Figure 2B). There 
were 126 unique to each cell line, or only repressed in 1/4 cell lines. Many genes that are established 
indicators of liver function (Alb, Agt, Asl, Aldob, Ass, Pah, Fbb, Fgb, Hpx, Pah, Pckl, Tat, and Ttr) were 
amongst the genes repressed �5 fold, which was expected since the SerpinAl promoter sequence was 
incorporated into the selection process. 
Based on the 268 genes that were shared between at least 2/4 cells (fulfilling both criteria), 
candidate genes were selected based on their established or proposed function. These included genes that 
are known to act as transcription factors or those that are involved in signal transduction pathways. From 
the genes repressed in cell variants, 14 candidate genes were identified that have the best potential to 
provide insight into the genetic programs involved with liver function. These genes included Bhlhb2, 
Creb313, Creg, Dppa4, Dppa5, Gas2, Hhex, lgfbpl, Mdk, Onecutl, Rnfl25, Sec16b, Stra8, and Tcfap2b 
(Table 1). 
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Analysis of Activated Genes 
It is also possible that the global genetic reprogramming seen in cell variants is the result of specific 
gene activation, which in turn may have downstream effects resulting in the repression of hepatic genes. 
Analysis of activated genes and identification of candidate genes was conducted using the same criteria as 
were applied to the repressed genes; genes had to be activated �5 fold in at least 2/4 cell lines and the 
genes had to be known or proposed to act as transcription factors or signal transduction factors. 
The total number of genes activated �5 fold ranged from 51-113 in the four variant cell lines, which was 
lower than the number of genes repressed >5 fold (230-284)(Figure 3A). Among the 4 variant cell lines (M38 
Hll HS2 M29), 113, 51, 98, and 100 genes were activated, respectively. The number of activated genes 
shared between cell lines was also lower. Only 2 genes were activated in 4/4 cell variant cell lines, while 
a total of 132 genes were shared among the four variant cell lines on the repressed side (Figure 3B). 
Quantitative Polymerase Chain Reaction (qPCR) 
Upon identification of candidate genes, a gene of specific interest, ONECUT1/HNF6, was stably 
transfected back into one of the variant cell lines (Hll) and analyzed by tit.CT values using qPCR to see the 
effect of introducing ONECUTl on the expression of genes indicative of liver function (eg. Alb, Pepck, etc.) 
Surprisingly, qPCR results of Fg14, Hll, and Hll-ONECUTl with a ONECUTl primer shows that ONECUTl is 
still expressed significantly more (>10 fold) in the parental Fg14 cell line than the previously transfected 
Hll-ONECUTl cell line. This is derived from converting the cycle difference to an expression difference. 
Given the cycle difference, the repression value can be calculated by raising 2 to the power of the cycle 
difference (so a 3.3 cycle difference represents a 10 fold difference in expression). There was approximately 
a 6 cycle difference between Hll-ONECUTl and Fg14, representing a 64 fold difference in expression for 
ONECUTl.Results also showed that there is little to no difference (<2 fold) between the Hll cell line and the 
Hll-ONECUTl cell line (Figure 4).qPCR data with a PCK primer (PCK is an established indicator of liver 
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function) showed that recovery of PCK expression was modest (approximately 2 fold) between Hll and 
Hll-ONECUTl. This is in comparison with Fg14, which shows a �  100 fold expression difference in PCK 
expression when compared to Hll or Hll-ONECUT1 (Figure 5). 
Discussion 
A total of 398 genes were repressed �5 fold in at least one of the variant cell lines, while 132 of 
these genes were repressed in all four variant cell lines. This indicates that: 1) gene silencing in each cell 
variant is extensive; and, 2) a high degree of overlap is present amongst cell variants. Despite a large degree 
of overlap, each cell line also has a distinct set of repressed and activated genes unique to that cell line, 
providing support that each variant cell line has lost hepatic function by a different mechanism. A total of 75 
genes were activated in� 5 fold in at least one of the variant cell lines, while only 2 of these genes were 
shared amongst all four of these cell lines. This shows that gene activation in cell variants is less extensive 
and that the overlap between cell lines is not nearly as profound. These results cannot give meaningful 
insight into the mechanism by which these variant cell lines lost hepatic function, as both the repressed and 
activated side may still be responsible for this differentiated state. In my study, thorough analysis of the 
repressed side was carried out, but that is not meant to downplay the potential importance of activated 
genes. Further genome-wide analysis of the activated genes and genetic rescue experiments designed for 
activated genes may provide meaningful insight into the mechanism by which these variant cell lines lost 
their hepatic function. 
Analysis of variability within the cell lines showed that the parental Fg14 cell line and the Hll and 
M38 variant cell lines showed little variation between gene expression values throughout the genome, with 
only 0-5 genes showing � S fold differences between the triplicates. The potential for false positives, 
however, was higher in both the HS2 and M29 cell lines. The HS2 cell line had a higher potential for false 
positives because of its much higher variability within the cell line, showing 22 genes with� S fold 
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differences, while the M29 cell line had a higher potential for providing false positives because there was 
only one sample. To minimize the possibility of these false positives showing up in our final analysis, we 
used the criteria that genes must be repressed or activated in 2/4 cell lines. By employing this strategy, 
however, it is possible that we missed repressed or activated genes unique to each cell line that may have 
some involvement with driving them to their dedifferentiated state. For this reason, the list of genes 
presented cannot be considered completely inclusive. 
A surprising result in our identification of repressed genes was that the transcription factors HNFla 
and HNF4 did not meet our criteria for repressed genes. This is because HNFla and HNF4 act as 
transcription factors driving expression of SERPINAl, the gene which is selected against in all variants and is 
significantly repressed in all the variant cell lines (55-95 fold). I believe, however, that this phenomenon 
could most likely be explained by the sensitivity limitations of the microarray data. Parental Fg14 microarray 
data for the transcription factors is around 400 units, and background noise from the microarray data is 
around 100 units, making a true fold repression not available by microarray. To test this, qPCR was used to 
determine relative expression values of both HNFla and HNF4. The qPCR data showed a �100 fold 
reduction in both of these genes, supporting the fact that low expression levels in the parent were the 
reason these genes did not meet our criteria. This indicates that genes expressed in low levels in the Fg14 
cell line may not have been identified by our scheme, therefore increasing the potential pool of missed 
genes that may be involved with driving liver function. 
Analysis by qPCR after stable transfection of ONECUTl into the Hll cell variant showed that 
ONECUTl expression differences between the variant cell line and the newly transfected cell line were 
modest (<2 fold) (Figure 4A). This is surprising because it is expected that ONECUTl expression would 
increase upon transfection. The reason for this discrepancy is unclear. It is possible that the transfection 
process may not have worked as per protocol, and thus, expression levels are unaltered. It is also possible, 
however, that genetic or molecular mechanisms may be responsible for ONECUTl not being expressed. 
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Further assessment needs to be completed to provide a more complete picture of why the gene is not being 
expressed after transfection. Since ONECUTl is not being expressed at a higher level, the cell line (as is) is 
not an ideal model to test for the effect of reintroducing ONECUTl on recovery of hepatic function, since 
there is modest difference between the Hll and the Hll-ONECUTl cell line at this point in time. Only one 
qPCR test for recovery of a hepatic indicator (PCK, Figure 5). is included in the results, but recovery of other 
hepatic genes (e.g., Alb, etc.) was not seen in additional tests. 
In conclusion, gene silencing in each cell variant is extensive and highly overlapping. A distinct set of 
unique genes in each cell line, however, indicates that the molecular mechanisms by which these cell lines 
have lost hepatic function are varying. In my genome-wide analysis it is likely that some activated or 
repressed genes (potentially involved with hepatic function) were not included in my analysis based on 
limitations by microarray sensitivity and my specific criteria. Genetic rescue experiments, designed with 
both ONECUTl and other candidate genes, are essential for identifying genes involved with hepatic function 
and the genetic programs responsible for establishing and maintaining liver specific gene expression. 
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Table 1. List of candidate genes selected from genes that are repressed � 5 fold in at least 2/4 cell lines. 
These genes were selected based on their established or proposed function, with emphasis on those 
known to act as signal transduction factors or transcription factors in the cell. 
Fold Repression 
M38 HS2 H11 M29 Gene Name Description 
6.2 1.7 3.6 5.5 Bhlhb2 Basic helix-loop-helix domain containing, Class 2B 
12.9 15.0 14.6 13.7 Creb313 cAMP responsive element binding protein 3-like 3 
3.6 6.4 2.7 5.9 Creg E1A-stimulated genes (predicted) 
17.4 18.7 18.7 16.7 Dppa4 Developmental pluripotency associated 4 (LOC680293) (predicted) 
12.2 11.9 11.9 10.1 Dppa5 Similar to DPPA5 developmental pluripotency associated 5 (RGD1564306) (predicted) 
9.3 8.5 7.9 8.8 Gas2 Growth arrest-specific 2. (RGD1563167) (predicted) 
5.1 6.0 2.8 5.8 Hhex Hematopoietically-expressed homeobox protein 
118.6 128.0 131.9 107.4 lgfbp1 Insulin like growth factor binding protein 1 
8.3 9.6 0.1 7.4 Mdk Midkine (neurite growth- promoting factor 2) 
10.7 5.3 14.9 16.9 Onecut1 One cut homeobox 1 
7.0 14.9 2.1 43.3 Rnf125 Ring Finger protein 125 (predicted) 
9.4 10.3 10.6 5.3 Sec16b SEC16 homolog B. (S cerevisiae homolog) 
19.1 19.7 19.7 19.0 StraB Stimulated by Retinoic Acid 8 (RGD1562852) (predicted) 
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Figure 1. Variability amongst cell line triplicates in each cell line. Differences in expression values (� 5 
fold) from Microarray data show the relative stability of each cell line. H11, Fg14, and M38 show only 0-5 
genes repressed amongst the triplicates, while the HS2 cell line shows more. The M29 cell line is not 
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Figure 2. Number of total genes repressed � 5 fold in each individual cell line (A) and the repressed 
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Figure 3. Activated genes in variant cell lines. The total number of genes activated in each cell line (A) 
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Figure 4. (A) shows qPCR data using 66CT values for Fg14, Hll, H11-HNF6, and H20 with a rat primer for 
HNF6. Relative expression of ONECUTl shows a �s cycle difference between Fg14 and the H11-HNF6 cell 
line even after stable transfection of HNF6 into Hll. This 5 cycle difference corresponds to a 25 fold 
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Figure 5. Amplification plot of parental, variant, and transfected cell lines with rPCK primer. Differences 
in expression of rPCK between Fg14, Hll, and Hll-ONECUTl cell lines shows that parental Fg14 cells 
express rPCK at a much higher level than either Hll or Hll-ONECUTl, as indicated by the 5-6 cycle 
difference. The expression differences between rPCK in Hll and Hll-ONECUTl are modest (:= 2 fold.) 
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